Jfs Wealth Advisors, LLC Relay Therapeutics, Inc. Transaction History

Jfs Wealth Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$8.24 - $12.97 $41 - $64	-5 Reduced 83.33%	1 $0
Q2 2023 Aug 07, 2023	SELL	$9.99 - $18.27 $39 - $73	-4 Reduced 40.0%	6 $0
Q1 2023 Apr 19, 2023	BUY	$15.0 - $22.76 $75 - $113	5 Added 100.0%	10 $0
Q4 2022 Feb 13, 2023	SELL	$14.16 - $24.02 $42 - $72	-3 Reduced 37.5%	5 $0
Q3 2022 Oct 21, 2022	SELL	$18.07 - $31.37 $36 - $62	-2 Reduced 20.0%	8 $0
Q2 2022 Aug 02, 2022	BUY	$13.31 - $34.88 $133 - $348	10 New	10 $0

204

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $500M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.